Pages that link to "Q43867525"
Jump to navigation
Jump to search
The following pages link to Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. (Q43867525):
Displaying 50 items.
- The role of IDO in brain tumor immunotherapy (Q26830399) (← links)
- 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity (Q27863347) (← links)
- Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury (Q28589204) (← links)
- IDO expression by dendritic cells: tolerance and tryptophan catabolism (Q29614752) (← links)
- The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. (Q33559343) (← links)
- Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes (Q34323684) (← links)
- Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone. (Q34612686) (← links)
- Pancreas and islet cell transplantation (Q34701213) (← links)
- Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes (Q34706913) (← links)
- Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy (Q34973801) (← links)
- Gene- and cell-based therapeutics for type I diabetes mellitus (Q35122170) (← links)
- Current status and prospects for gene and cell therapeutics for type 1 diabetes mellitus (Q35583901) (← links)
- Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration (Q35596521) (← links)
- The role of pDC, recipient T(reg) and donor T(reg) in HSC engraftment: Mechanisms of facilitation (Q35603220) (← links)
- Immunotherapy in allogeneic hematopoietic stem cell transplantation--not just a case for effector cells (Q36090223) (← links)
- Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models. (Q36379002) (← links)
- Indoleamine-2,3-dioxygenase modulation of allergic immune responses (Q36395748) (← links)
- A theranostic small interfering RNA nanoprobe protects pancreatic islet grafts from adoptively transferred immune rejection (Q36410697) (← links)
- Strategies to improve non-viral vectors--potential applications in clinical transplantation (Q36481006) (← links)
- Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO (Q36627360) (← links)
- Immune rejection after pancreatic islet cell transplantation: in vivo dual contrast-enhanced MR imaging in a mouse model. (Q36628967) (← links)
- Cell replacement therapy and the evasion of destructive immunity (Q36672119) (← links)
- The role of indoleamine 2,3-dioxygenase in transplantation (Q36713343) (← links)
- Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation. (Q37013795) (← links)
- Indoleamine 2,3-dioxygenase in transplantation (Q37067533) (← links)
- Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach. (Q37144901) (← links)
- Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion (Q37224538) (← links)
- Protection against type 1 diabetes upon Coxsackievirus B4 infection and iNKT-cell stimulation: role of suppressive macrophages (Q37251100) (← links)
- IDO: a double-edged sword for T(H)1/T(H)2 regulation (Q37281950) (← links)
- The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer (Q37329058) (← links)
- Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases (Q37522460) (← links)
- Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit? (Q37533878) (← links)
- Immune escape mechanisms of intraocular tumors (Q37535138) (← links)
- Role of IDO in organ transplantation: promises and difficulties (Q37610449) (← links)
- Immune cell crosstalk in type 1 diabetes (Q37767586) (← links)
- Reprogramming gut and pancreas endocrine cells to treat diabetes. (Q37913508) (← links)
- NAD metabolism and oxidative stress: the golden nucleotide on a crown of thorns. (Q37984791) (← links)
- Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance. (Q38047057) (← links)
- Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease (Q38150700) (← links)
- Gene therapy modalities in lung transplantation. (Q38243641) (← links)
- Kynurenine, a Tryptophan Metabolite That Accumulates With Age, Induces Bone Loss (Q38670358) (← links)
- Nicotinic acid-mediated activation of both membrane and nuclear receptors towards therapeutic glucocorticoid mimetics for treating multiple sclerosis (Q39303280) (← links)
- Function of the tryptophan metabolite, L-kynurenine, in human corneal endothelial cells (Q39825658) (← links)
- Indoleamine 2,3-dioxygenase attenuates inhibitor development in gene-therapy-treated hemophilia A mice (Q39877042) (← links)
- Suppression of cytotoxic and proliferative xenogeneic T-cell responses by transgenic expression of indoleamine 2,3-dioxygenase (Q40003679) (← links)
- Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression (Q40315535) (← links)
- Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction (Q40495763) (← links)
- Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division (Q40686234) (← links)
- Pancreatic islet transplants and IDO: when starving the enemy does you good (Q41889772) (← links)
- IDO induces expression of a novel tryptophan transporter in mouse and human tumor cells (Q41963936) (← links)